COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis
In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options. Using an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets as...
Saved in:
Published in | EBioMedicine Vol. 82; p. 104185 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.08.2022
Elsevier |
Subjects | |
Online Access | Get full text |
ISSN | 2352-3964 2352-3964 |
DOI | 10.1016/j.ebiom.2022.104185 |
Cover
Abstract | In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options.
Using an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR.
COVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2.
Like IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases.
This work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780). |
---|---|
AbstractList | In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options.
Using an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR.
COVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2.
Like IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases.
This work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780). SummaryBackgroundIn the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post- COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options. MethodsUsing an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR. FindingsCOVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2. InterpretationLike IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases. FundingThis work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780). In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options.BACKGROUNDIn the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options.Using an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR.METHODSUsing an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR.COVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2.FINDINGSCOVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2.Like IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases.INTERPRETATIONLike IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases.This work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780).FUNDINGThis work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780). Background: In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into pathogenesis, disease models, or treatment options. Methods: Using an AI-guided approach, we analyzed > 1000 human lung transcriptomic datasets associated with various lung conditions using two viral pandemic signatures (ViP and sViP) and one covid lung-derived signature. Upon identifying similarities between COVID-19 and idiopathic pulmonary fibrosis (IPF), we subsequently dissected the basis for such similarity from molecular, cytopathic, and immunologic perspectives using a panel of IPF-specific gene signatures, alongside signatures of alveolar type II (AT2) cytopathies and of prognostic monocyte-driven processes that are known drivers of IPF. Transcriptome-derived findings were used to construct protein-protein interaction (PPI) network to identify the major triggers of AT2 dysfunction. Key findings were validated in hamster and human adult lung organoid (ALO) pre-clinical models of COVID-19 using immunohistochemistry and qPCR. Findings: COVID-19 resembles IPF at a fundamental level; it recapitulates the gene expression patterns (ViP and IPF signatures), cytokine storm (IL15-centric), and the AT2 cytopathic changes, e.g., injury, DNA damage, arrest in a transient, damage-induced progenitor state, and senescence-associated secretory phenotype (SASP). These immunocytopathic features were induced in pre-clinical COVID models (ALO and hamster) and reversed with effective anti-CoV-2 therapeutics in hamsters. PPI-network analyses pinpointed ER stress as one of the shared early triggers of both diseases, and IHC studies validated the same in the lungs of deceased subjects with COVID-19 and SARS-CoV-2-challenged hamster lungs. Lungs from tg-mice, in which ER stress is induced specifically in the AT2 cells, faithfully recapitulate the host immune response and alveolar cytopathic changes that are induced by SARS-CoV-2. Interpretation: Like IPF, COVID-19 may be driven by injury-induced ER stress that culminates into progenitor state arrest and SASP in AT2 cells. The ViP signatures in monocytes may be key determinants of prognosis. The insights, signatures, disease models identified here are likely to spur the development of therapies for patients with IPF and other fibrotic interstitial lung diseases. Funding: This work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780). |
ArticleNumber | 104185 |
Author | Dan, Jennifer M. Fonseca, Ayden G. Espinoza, Celia R. Ghosh, Pradipta Castillo, Vanessa Tindle, Courtney Das, Soumita Sinha, Saptarshi Sahoo, Debashis Katkar, Gajanan D. |
Author_xml | – sequence: 1 givenname: Saptarshi surname: Sinha fullname: Sinha, Saptarshi organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA – sequence: 2 givenname: Vanessa surname: Castillo fullname: Castillo, Vanessa organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA – sequence: 3 givenname: Celia R. surname: Espinoza fullname: Espinoza, Celia R. organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA – sequence: 4 givenname: Courtney surname: Tindle fullname: Tindle, Courtney organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA – sequence: 5 givenname: Ayden G. surname: Fonseca fullname: Fonseca, Ayden G. organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA – sequence: 6 givenname: Jennifer M. surname: Dan fullname: Dan, Jennifer M. organization: Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA – sequence: 7 givenname: Gajanan D. surname: Katkar fullname: Katkar, Gajanan D. organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA – sequence: 8 givenname: Soumita surname: Das fullname: Das, Soumita organization: Department of Pathology, University of California San Diego, La Jolla, CA 92093, USA – sequence: 9 givenname: Debashis surname: Sahoo fullname: Sahoo, Debashis email: dsahoo@ucsd.edu organization: Department of Pediatrics, University of California San Diego, La Jolla, CA 92093, USA – sequence: 10 givenname: Pradipta orcidid: 0000-0002-8917-3201 surname: Ghosh fullname: Ghosh, Pradipta email: prghosh@ucsd.edu organization: Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA 92093, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35870428$$D View this record in MEDLINE/PubMed |
BookMark | eNqFUk1rGzEQXUpKk6b5BYWyx17sSqPdlURpILhfhkAOTXus0GpnbbnrlSNpXfzvq42TkASKL5KYee_NaOa9zo5612OWvaVkSgmtPqymWFu3ngIBSJGCivJFdgKshAmTVXH06H2cnYWwIoTQskhB8So7TicnBYiT7Pfs6tf884TKvBv6Rd7YgDpgHpbaY8gbb7fo84tryM0uuo2OS2vyFnUcxvRfG5f5vLH3ic3QrV2v_S5vbe1dsOFN9rLVXcCzu_s0-_n1y_Xs--Ty6tt8dnE5MRWDOBF1Y4jUElgB3FAOmoIGFIhlWUnKCNctQMGLoiyLumWNQKJFLanmuiBEsNNsvtdtnF6pjbfr1IVy2qrbgPMLpX20pkPVlK2UphSCy8SFQmpkEgQxXJdtbVjSOt9rbYZ6jY3BPnrdPRF9muntUi3cVkmQXABPAu_vBLy7GTBEtbbBYNfpHt0QFFSScS4lH6HvHtd6KHK_oARge4BJ8wwe2wcIJWp0glqpWyeo0Qlq74TEks9YxkYdrRsbtt0B7qc9F9O-tha9CsZib7CxHk1MA7UH-OfP-KazvTW6-4M7DCs3-D5ZQVEVQBH1Y_TpaFMAQlhVjV_--H-Bg-X_AcC091E |
CitedBy_id | crossref_primary_10_1186_s12951_023_01821_6 crossref_primary_10_3390_microorganisms11040895 crossref_primary_10_1513_AnnalsATS_202406_651ST crossref_primary_10_26508_lsa_202302026 crossref_primary_10_1165_rcmb_2023_0426TR crossref_primary_10_3389_fphar_2023_1143158 crossref_primary_10_1038_s41467_024_52810_8 crossref_primary_10_3390_ijms242216410 crossref_primary_10_1186_s12931_024_02738_w crossref_primary_10_3390_cimb46050261 crossref_primary_10_1002_ptr_8070 crossref_primary_10_1016_j_pccm_2023_10_007 crossref_primary_10_1016_j_envint_2024_108415 crossref_primary_10_3389_fpubh_2023_1295457 crossref_primary_10_1111_apha_14059 crossref_primary_10_3390_biom14020236 crossref_primary_10_1152_ajpcell_00239_2023 crossref_primary_10_1007_s00134_022_06877_w crossref_primary_10_3390_biology12091196 crossref_primary_10_1016_j_ebiom_2024_105136 crossref_primary_10_1186_s13287_023_03414_4 |
Cites_doi | 10.1016/j.stem.2020.06.020 10.1016/j.ebiom.2021.103513 10.4049/jimmunol.1801648 10.1038/s41467-021-23328-0 10.1038/nature03712 10.1038/s41467-021-21085-8 10.1056/NEJMra1705751 10.1017/S1431927611011925 10.1056/NEJMoa2116044 10.1186/gb-2008-9-10-r157 10.1016/S2213-2600(17)30349-1 10.1183/13993003.00642-2015 10.3389/fimmu.2019.03150 10.1164/rccm.202006-2441LE 10.1165/rcmb.2019-0071OC 10.1172/JCI93556 10.1016/j.immuni.2020.12.003 10.1016/j.ebiom.2021.103390 10.3390/cells10030611 10.1093/nar/gkm284 10.3390/jcm9041178 10.1084/jem.20141732 10.1073/pnas.1504780112 10.2174/1871528113666140713164506 10.1056/NEJMoa2015432 10.1080/20018525.2020.1853658 10.3390/ijms22116151 10.1513/AnnalsATS.201303-069FR 10.18632/aging.202463 10.3389/fimmu.2020.587517 10.24018/ejmed.2021.3.1.670 10.1038/nm1578 10.1097/MCP.0000000000000301 10.21037/jtd-21-462 10.1056/NEJMe0903992 10.1164/rccm.202007-2638LE 10.1148/radiol.2021204482 10.1164/rccm.201902-0451OC 10.1016/S0140-6736(03)14630-2 10.1126/scitranslmed.abb5883 10.1038/srep07027 10.1371/journal.pone.0096801 10.1513/AnnalsATS.202008-1002OC 10.1016/j.ajpath.2013.03.014 10.1126/sciadv.abh2434 10.1093/nar/gkaa1074 10.1038/s41564-020-00835-2 10.1164/rccm.202007-2794OC 10.1186/1755-8794-4-70 10.1146/annurev-immunol-032713-120231 10.1093/infdis/jis340 10.1002/jum.15563 10.1016/j.ebiom.2021.103595 10.1172/JCI139519 10.1073/pnas.0913635107 10.1126/sciimmunol.abk1741 10.1038/nm.4192 10.1165/rcmb.2021-0205LE 10.1016/S2213-2600(21)00077-1 10.1038/s41556-020-0542-8 10.1172/JCI118321 10.1016/S2213-2600(20)30225-3 10.1172/JCI68782 10.3390/ijms22105131 10.1038/s41467-022-30357-w 10.1186/ar2284 10.1016/j.idcr.2020.e01041 10.1253/circj.CJ-12-1544 10.1186/cc9259 10.2741/pardo 10.1016/j.trsl.2019.12.002 10.1126/sciadv.aba1983 10.3390/ijms22126214 10.1371/journal.ppat.1004869 10.1371/journal.pone.0215565 10.1038/ncomms5451 10.1038/d41586-020-02598-6 10.1084/jem.180.4.1395 10.1164/rccm.202010-3918ED 10.1016/j.autrev.2020.102537 10.1016/j.trsl.2013.06.004 10.1126/scitranslmed.abe4282 10.4049/jimmunol.1900579 10.1128/JVI.01965-17 10.1126/science.abc7520 10.1183/13993003.02951-2021 10.1016/S2213-2600(21)00174-0 10.1111/acel.12161 10.1056/NEJMra052211 10.1513/AnnalsATS.202102-223ED 10.1155/2011/531302 10.1038/s12276-019-0371-7 10.1016/j.rmed.2018.06.012 10.1136/thoraxjnl-2021-217031 10.1101/gad.1836009 10.18632/aging.104097 10.1038/s41577-021-00536-9 10.1016/j.exger.2020.110836 10.1002/ctm2.224 10.1016/j.celrep.2016.11.001 10.1038/s41556-020-0561-5 10.1093/nar/gkx1132 10.7554/eLife.66417 10.1371/journal.pone.0224839 10.1164/rccm.201712-2410OC 10.3390/ijms21072269 10.1164/rccm.202004-1274OC 10.1165/rcmb.2013-0310OC 10.1073/pnas.1117988108 10.1097/CCM.0000000000005089 10.1126/scitranslmed.aax5866 10.1067/mai.2001.119556 10.1056/NEJMoa1211721 10.1038/s41586-021-03995-1 10.1038/s41467-020-17358-3 10.1097/SHK.0000000000000633 10.1038/s41598-017-01765-6 10.1038/s41591-020-0901-9 10.1016/S2213-2600(20)30222-8 10.1371/journal.pone.0118528 10.1091/mbc.E19-01-0013 10.3390/genes10070531 10.15252/embj.2020105912 10.1172/jci.insight.90558 10.1126/scitranslmed.abj7790 |
ContentType | Journal Article |
Copyright | 2022 The Author(s) The Author(s) Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved. 2022 The Author(s) 2022 |
Copyright_xml | – notice: 2022 The Author(s) – notice: The Author(s) – notice: Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved. – notice: 2022 The Author(s) 2022 |
DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1016/j.ebiom.2022.104185 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2352-3964 |
EndPage | 104185 |
ExternalDocumentID | oai_doaj_org_article_d5f99c58879a40249ae39280c7a5fbc3 PMC9297827 35870428 10_1016_j_ebiom_2022_104185 S2352396422003668 1_s2_0_S2352396422003668 |
Genre | Journal Article |
GrantInformation | This work was supported by the National Institutes for Health grants R01- GM138385 and AI155696 and funding from the Tobacco-Related disease Research Program (R01RG3780). |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R25 AI147376 – fundername: NIGMS NIH HHS grantid: R01 GM138385 – fundername: NIAID NIH HHS grantid: R01 AI155696 – fundername: NIAID NIH HHS grantid: U19 AI142742 – fundername: NCATS NIH HHS grantid: UG3 TR003355 |
GroupedDBID | .1- .FO 0R~ 4.4 457 53G 5VS AAEDT AAEDW AAIKJ AALRI AAMRU AAXUO AAYWO ABMAC ACGFS ACVFH ADBBV ADCNI ADEZE ADRAZ ADVLN AEUPX AEXQZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BCNDV EBS EJD FDB GROUPED_DOAJ HYE HZ~ IPNFZ KQ8 M41 M48 O9- OK1 RIG ROL RPM SSZ Z5R 0SF 6I. AACTN AAFTH AFCTW NCXOZ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c632t-8bdc09a923427c172a12a2e8ee55691307af224744554bf3d8e0a8b91a7a40083 |
IEDL.DBID | M48 |
ISSN | 2352-3964 |
IngestDate | Wed Aug 27 01:23:23 EDT 2025 Thu Aug 21 18:18:05 EDT 2025 Fri Sep 05 10:11:24 EDT 2025 Mon Jul 21 05:59:39 EDT 2025 Tue Jul 01 00:39:03 EDT 2025 Thu Apr 24 23:01:19 EDT 2025 Tue Jul 25 20:57:56 EDT 2023 Tue Feb 25 20:10:31 EST 2025 Tue Aug 26 17:01:35 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Senescence Immune response ER-stress Interleukin 15 (IL15) Damage-associated transient progenitor (DATP) Artificial intelligence/machine learning Alveolar type II pneumocytes |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. Copyright © 2022 The Author(s). Published by Elsevier B.V. All rights reserved. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c632t-8bdc09a923427c172a12a2e8ee55691307af224744554bf3d8e0a8b91a7a40083 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Co-Corresponding. |
ORCID | 0000-0002-8917-3201 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1016/j.ebiom.2022.104185 |
PMID | 35870428 |
PQID | 2693779977 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_d5f99c58879a40249ae39280c7a5fbc3 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9297827 proquest_miscellaneous_2693779977 pubmed_primary_35870428 crossref_primary_10_1016_j_ebiom_2022_104185 crossref_citationtrail_10_1016_j_ebiom_2022_104185 elsevier_sciencedirect_doi_10_1016_j_ebiom_2022_104185 elsevier_clinicalkeyesjournals_1_s2_0_S2352396422003668 elsevier_clinicalkey_doi_10_1016_j_ebiom_2022_104185 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-08-01 |
PublicationDateYYYYMMDD | 2022-08-01 |
PublicationDate_xml | – month: 08 year: 2022 text: 2022-08-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | EBioMedicine |
PublicationTitleAlternate | EBioMedicine |
PublicationYear | 2022 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Rieppo, Janssen, Rahunen, Lehenkari, Finnilä, Saarakkala (bib0034) 2019; 14 Garcia (bib0065) 2018; 128 Lee IY, Ho JM, Chen MS. CLUGO: a clustering algorithm for automated functional annotations based on gene ontology. In Fifth IEEE International Conference on Data Mining (ICDM'05) 2005 Nov 27 (pp. 4-pp). IEEE. Borok, Horie, Flodby (bib0089) 2020; 201 Lederer, Martinez (bib0043) 2018; 378 Carson, Giri, Lindemann (bib0025) 1994; 180 Chamberlain, Crowley, Kobayashi, Eliceiri, Vanderby (bib0033) 2011; 17 Bonham, Strek, Patterson (bib0037) 2016; 22 Sheahan, Sims, Zhou (bib0075) 2020; 12 Jayk Bernal, Gomes da Silva, Musungaie (bib0077) 2022; 386 van der Meer, Orsel, Barkema (bib0052) 2010; 51 Kaarteenaho, Kinnula (bib0012) 2011; 2011 Verheyden, Sun (bib0096) 2020; 22 Xi, Zhigang, Ting (bib0110) 2020; 6 Ghosh, Katkar, Shimizu (bib0035) 2022; 13 Evren, Ringqvist, Tripathi (bib0061) 2021; 54 Sahoo, Dill, Tibshirani, Plevritis (bib0019) 2007; 35 Ammar, Sivakumar, Jarai, Thompson (bib0042) 2019; 14 Zaki, van Boheemen, Bestebroer, Osterhaus, Fouchier (bib0057) 2012; 367 Cox, Wolf, Plemper (bib0072) 2021; 6 Podolanczuk, Richeldi (bib0106) 2020; 202 McGroder, Zhang, Choudhury (bib0119) 2021; 76 Bharat, Querrey, Markov (bib0015) 2020; 12 Kølner-Augustson, Prior, Skivild, Aalestrup, Bendstrup (bib0049) 2020; 8 Parimon, Hohmann, Yao (bib0098) 2021; 22 Takada, Ohashi, Hayashi (bib0113) 2018; 141 Lee, Yu, Trimpert (bib0128) 2021; 599 Parimon, Yao, Stripp, Noble, Chen (bib0064) 2020; 21 Lopez-Sanchez, Dunkel, Roh (bib0029) 2014; 5 Wagstaffe, Pickering, Houghton (bib0023) 2019; 203 Patterson, Strek (bib0038) 2013; 10 D'Agnillo, Walters, Xiao (bib0130) 2021; 13 Varghese, Bukhari, Malhotra, De (bib0032) 2014; 9 Bonaventura, Vecchié, Dagna (bib0084) 2021; 21 Rock, Barkauskas, Cronce (bib0090) 2011; 108 Nosaka, Ishida, Kimura (bib0087) 2019; 10 Hoek, Samir, Howard (bib0024) 2015; 10 Wu, Byers, Jin (bib0060) 2015; 212 Herazo-Maya, Sun, Molyneaux (bib0027) 2017; 5 Kobayashi, Tata, Konkimalla (bib0069) 2020; 22 Sahoo, Katkar, Khandelwal (bib0018) 2021; 68 Cheon, Li, Son (bib0014) 2021; 6 Maruhashi, Higashi (bib0085) 2021; 22 Lamers, van der Vaart, Knoops (bib0081) 2021; 40 Sahoo, Seita, Bhattacharya (bib0132) 2010; 107 Yao, Guan, Carraro (bib0070) 2021; 203 Ackermann, Verleden, Kuehnel (bib0013) 2020; 383 Kuba, Imai, Penninger (bib0103) 2013; 77 Ahmad Alhiyari, Ata, Islam Alghizzawi, Bint, Salih Abdulhadi, Yousaf (bib0007) 2021; 23 Gallay, Uzunhan, Borie (bib0107) 2021; 203 Alder, Barkauskas, Limjunyawong (bib0115) 2015; 112 Marshall (bib0048) 2020; 585 Firdaus, Razak, Reza, Khan, Shameem (bib0108) 2020; 14 Zhai, Franco, Atmar (bib0058) 2015; 11 Schneider, Chevillotte, Rice (bib0117) 2014; 32 Bermejo-Martin, Martin-Loeches, Rello (bib0053) 2010; 14 Zhong, Zheng, Li (bib0055) 2003; 362 Liu, Liu (bib0097) 2020; 132 Mongelli, Barbi, Gottardi Zamperla (bib0120) 2021; 22 Rogers, Zhao, Huang (bib0031) 2020; 369 Gagiannis, Steinestel, Hackenbroch (bib0009) 2020; 11 Strunz, Simon, Ansari (bib0068) 2020; 11 Toots, Yoon, Hart, Natchus, Painter, Plemper (bib0073) 2020; 218 Atabati, Dehghani-Samani, Mortazavimoghaddam (bib0006) 2020; 56 Dadhwal, Sharma, Surani (bib0005) 2021; 13 Toots, Yoon, Cox (bib0074) 2019; 11 Spagnolo, Balestro, Aliberti (bib0001) 2020; 8 Szklarczyk, Gable, Nastou (bib0021) 2021; 49 Choi, Park, Tsagkogeorga (bib0067) 2020; 27 Reyfman, Walter, Joshi (bib0044) 2019; 199 Zhou, Mao, Zhou (bib0093) 2014; 13 Imai, Kuba, Rao (bib0036) 2005; 436 Chen, Chen, Liang (bib0125) 2020; 52 Yang, Gu, Zhao (bib0078) 2014; 4 Bloem, Mostard, Stoot (bib0050) 2020; 9 Inlay, Bhattacharya, Sahoo (bib0100) 2009; 23 McGonagle, Sharif, O'Regan, Bridgewood (bib0111) 2020; 19 Carson, Ross, Baiocchi (bib0026) 1995; 96 Xu, Liu, Liao (bib0046) 2020; 10 Bharat, Machuca, Querrey (bib0017) 2021; 9 Esposito, Menon, Ghosh (bib0104) 2020; 202 Borok, Horie, Flodby (bib0121) 2020; 201 Fabregat, Jupe, Matthews (bib0020) 2018; 46 Froidure, Mahieu, Hoton (bib0118) 2020; 12 Dabydeen, Desai, Sahoo (bib0133) 2019; 30 Abdelnabi, Foo, Kaptein (bib0071) 2021; 72 Bloem, Mostard, Stoot, Vercoulen, Peters, Spruit (bib0051) 2021; 13 Bauer, Tedrow, de Bernard (bib0040) 2015; 52 Momen, Khan, Saber (bib0109) 2021; 3 Drake, Docherty, Harrison (bib0105) 2020; 202 Aviv (bib0095) 2021; 70 Bakowski, Beutler, Wolff (bib0030) 2021; 12 Beigel, Farrar, Han (bib0056) 2005; 353 Zhang, Luo, Zhong (bib0063) 2019; 10 Sodhi, Nguyen, Yamaguchi (bib0101) 2019; 203 Adams, Schupp, Poli (bib0045) 2020; 6 Gangwar, Kumar Sharma, Panzade, Awasthi, Agrawal, Shankar (bib0041) 2017; 7 Vasarmidi, Tsitoura, Spandidos, Tzanakis, Antoniou (bib0079) 2020; 20 Myall, Mukherjee, Castanheira (bib0002) 2021; 18 Fink, Orlova-Fink, Schindler (bib0022) 2020 Sanchez-Vazquez, Guío-Carrión, Zapatero-Gaviria, Martínez, Blasco (bib0094) 2021; 13 Urakova, Kuznetsova, Crossman (bib0076) 2018; 92 Rana, Jiang, Liu (bib0126) 2020; 62 Frank, Peng, Zepp (bib0092) 2016; 17 Senchenkova, Komoto, Russell (bib0086) 2013; 183 Abdul-Careem, Mian (bib0116) 2012; 206 Tindle, Fuller, Fonseca (bib0028) 2021; 10 Lipskaia, Maisonnasse, Fouillade (bib0129) 2021; 66 Wuttge, Wildt, Geborek, Wollheim, Scheja, Akesson (bib0114) 2007; 9 Xu, Mizuno, Sridharan (bib0123) 2016; 1 Pardo, Selman (bib0066) 2002; 7 Sahoo, Dill, Gentles, Tibshirani, Plevritis (bib0131) 2008; 9 Alharthy, Abuhamdah, Balhamar (bib0008) 2020; 40 Katzen, Beers (bib0088) 2020; 130 Gaddam, Chambers, Bhatia (bib0099) 2014; 13 Ju, Jiang, Jaworski (bib0134) 2007; 13 Muro, Taha, Tsicopoulos (bib0112) 2001; 108 Croci, Vaira, Trabattoni (bib0016) 2021; 10 Liang, Zhang, Xie (bib0122) 2016; 22 Barkauskas, Cronce, Rackley (bib0091) 2013; 123 van Gassel, Bels, Remij (bib0011) 2021; 49 Meltzer, Barry, D'Amico (bib0039) 2011; 4 Jia (bib0102) 2016; 46 Baden, Drazen, Kritek, Curfman, Morrissey, Campion (bib0054) 2009; 360 Barrett, Cornwell, Myndzar (bib0083) 2021; 7 Liao, Liu, Yuan (bib0059) 2020; 26 Leahy, McManus, Doherty (bib0062) 2016; 47 Pang, Xu, Aondio (bib0080) 2021; 12 Wells, Devaraj, Desai (bib0003) 2021; 299 Evangelou, Veroutis, Paschalaki (bib0127) 2022 Chilosi, Carloni, Rossi, Poletti (bib0124) 2013; 162 Aronson, Podolanczuk (bib0004) 2021; 18 George, Wells, Jenkins (bib0010) 2020; 8 Wu, Liu, Zhou (bib0047) 2021; 9 Bloem (10.1016/j.ebiom.2022.104185_bib0050) 2020; 9 Bakowski (10.1016/j.ebiom.2022.104185_bib0030) 2021; 12 Wells (10.1016/j.ebiom.2022.104185_bib0003) 2021; 299 Yao (10.1016/j.ebiom.2022.104185_bib0070) 2021; 203 Takada (10.1016/j.ebiom.2022.104185_bib0113) 2018; 141 Maruhashi (10.1016/j.ebiom.2022.104185_bib0085) 2021; 22 Liu (10.1016/j.ebiom.2022.104185_bib0097) 2020; 132 Lee (10.1016/j.ebiom.2022.104185_bib0128) 2021; 599 Dadhwal (10.1016/j.ebiom.2022.104185_bib0005) 2021; 13 Evangelou (10.1016/j.ebiom.2022.104185_bib0127) 2022 George (10.1016/j.ebiom.2022.104185_bib0010) 2020; 8 Sahoo (10.1016/j.ebiom.2022.104185_bib0018) 2021; 68 Gallay (10.1016/j.ebiom.2022.104185_bib0107) 2021; 203 Wu (10.1016/j.ebiom.2022.104185_bib0060) 2015; 212 Mongelli (10.1016/j.ebiom.2022.104185_bib0120) 2021; 22 Chilosi (10.1016/j.ebiom.2022.104185_bib0124) 2013; 162 Carson (10.1016/j.ebiom.2022.104185_bib0026) 1995; 96 Rogers (10.1016/j.ebiom.2022.104185_bib0031) 2020; 369 Garcia (10.1016/j.ebiom.2022.104185_bib0065) 2018; 128 Podolanczuk (10.1016/j.ebiom.2022.104185_bib0106) 2020; 202 Alder (10.1016/j.ebiom.2022.104185_bib0115) 2015; 112 Rana (10.1016/j.ebiom.2022.104185_bib0126) 2020; 62 Rieppo (10.1016/j.ebiom.2022.104185_bib0034) 2019; 14 Inlay (10.1016/j.ebiom.2022.104185_bib0100) 2009; 23 Ammar (10.1016/j.ebiom.2022.104185_bib0042) 2019; 14 Bharat (10.1016/j.ebiom.2022.104185_bib0017) 2021; 9 Varghese (10.1016/j.ebiom.2022.104185_bib0032) 2014; 9 Gaddam (10.1016/j.ebiom.2022.104185_bib0099) 2014; 13 Lederer (10.1016/j.ebiom.2022.104185_bib0043) 2018; 378 Kaarteenaho (10.1016/j.ebiom.2022.104185_bib0012) 2011; 2011 Xu (10.1016/j.ebiom.2022.104185_bib0046) 2020; 10 Zhang (10.1016/j.ebiom.2022.104185_bib0063) 2019; 10 Bharat (10.1016/j.ebiom.2022.104185_bib0015) 2020; 12 Bonham (10.1016/j.ebiom.2022.104185_bib0037) 2016; 22 Zhai (10.1016/j.ebiom.2022.104185_bib0058) 2015; 11 Chamberlain (10.1016/j.ebiom.2022.104185_bib0033) 2011; 17 Zhou (10.1016/j.ebiom.2022.104185_bib0093) 2014; 13 Chen (10.1016/j.ebiom.2022.104185_bib0125) 2020; 52 Hoek (10.1016/j.ebiom.2022.104185_bib0024) 2015; 10 Toots (10.1016/j.ebiom.2022.104185_bib0073) 2020; 218 Aronson (10.1016/j.ebiom.2022.104185_bib0004) 2021; 18 Ackermann (10.1016/j.ebiom.2022.104185_bib0013) 2020; 383 Firdaus (10.1016/j.ebiom.2022.104185_bib0108) 2020; 14 Parimon (10.1016/j.ebiom.2022.104185_bib0064) 2020; 21 Dabydeen (10.1016/j.ebiom.2022.104185_bib0133) 2019; 30 Bloem (10.1016/j.ebiom.2022.104185_bib0051) 2021; 13 Muro (10.1016/j.ebiom.2022.104185_bib0112) 2001; 108 Momen (10.1016/j.ebiom.2022.104185_bib0109) 2021; 3 Senchenkova (10.1016/j.ebiom.2022.104185_bib0086) 2013; 183 Borok (10.1016/j.ebiom.2022.104185_bib0121) 2020; 201 Aviv (10.1016/j.ebiom.2022.104185_bib0095) 2021; 70 Parimon (10.1016/j.ebiom.2022.104185_bib0098) 2021; 22 Yang (10.1016/j.ebiom.2022.104185_bib0078) 2014; 4 Abdul-Careem (10.1016/j.ebiom.2022.104185_bib0116) 2012; 206 Adams (10.1016/j.ebiom.2022.104185_bib0045) 2020; 6 Zhong (10.1016/j.ebiom.2022.104185_bib0055) 2003; 362 Choi (10.1016/j.ebiom.2022.104185_bib0067) 2020; 27 Toots (10.1016/j.ebiom.2022.104185_bib0074) 2019; 11 Croci (10.1016/j.ebiom.2022.104185_bib0016) 2021; 10 Lipskaia (10.1016/j.ebiom.2022.104185_bib0129) 2021; 66 Borok (10.1016/j.ebiom.2022.104185_bib0089) 2020; 201 Liang (10.1016/j.ebiom.2022.104185_bib0122) 2016; 22 Wuttge (10.1016/j.ebiom.2022.104185_bib0114) 2007; 9 Leahy (10.1016/j.ebiom.2022.104185_bib0062) 2016; 47 Ghosh (10.1016/j.ebiom.2022.104185_bib0035) 2022; 13 Sheahan (10.1016/j.ebiom.2022.104185_bib0075) 2020; 12 Cox (10.1016/j.ebiom.2022.104185_bib0072) 2021; 6 Evren (10.1016/j.ebiom.2022.104185_bib0061) 2021; 54 Myall (10.1016/j.ebiom.2022.104185_bib0002) 2021; 18 Baden (10.1016/j.ebiom.2022.104185_bib0054) 2009; 360 Beigel (10.1016/j.ebiom.2022.104185_bib0056) 2005; 353 Sahoo (10.1016/j.ebiom.2022.104185_bib0131) 2008; 9 Zaki (10.1016/j.ebiom.2022.104185_bib0057) 2012; 367 McGonagle (10.1016/j.ebiom.2022.104185_bib0111) 2020; 19 Ahmad Alhiyari (10.1016/j.ebiom.2022.104185_bib0007) 2021; 23 Kølner-Augustson (10.1016/j.ebiom.2022.104185_bib0049) 2020; 8 Kobayashi (10.1016/j.ebiom.2022.104185_bib0069) 2020; 22 Liao (10.1016/j.ebiom.2022.104185_bib0059) 2020; 26 Katzen (10.1016/j.ebiom.2022.104185_bib0088) 2020; 130 Rock (10.1016/j.ebiom.2022.104185_bib0090) 2011; 108 Urakova (10.1016/j.ebiom.2022.104185_bib0076) 2018; 92 Jayk Bernal (10.1016/j.ebiom.2022.104185_bib0077) 2022; 386 Alharthy (10.1016/j.ebiom.2022.104185_bib0008) 2020; 40 Nosaka (10.1016/j.ebiom.2022.104185_bib0087) 2019; 10 Pardo (10.1016/j.ebiom.2022.104185_bib0066) 2002; 7 Meltzer (10.1016/j.ebiom.2022.104185_bib0039) 2011; 4 Vasarmidi (10.1016/j.ebiom.2022.104185_bib0079) 2020; 20 Patterson (10.1016/j.ebiom.2022.104185_bib0038) 2013; 10 Sahoo (10.1016/j.ebiom.2022.104185_bib0132) 2010; 107 Imai (10.1016/j.ebiom.2022.104185_bib0036) 2005; 436 Drake (10.1016/j.ebiom.2022.104185_bib0105) 2020; 202 Bauer (10.1016/j.ebiom.2022.104185_bib0040) 2015; 52 Fabregat (10.1016/j.ebiom.2022.104185_bib0020) 2018; 46 Kuba (10.1016/j.ebiom.2022.104185_bib0103) 2013; 77 Atabati (10.1016/j.ebiom.2022.104185_bib0006) 2020; 56 Fink (10.1016/j.ebiom.2022.104185_bib0022) 2020 Xu (10.1016/j.ebiom.2022.104185_bib0123) 2016; 1 Herazo-Maya (10.1016/j.ebiom.2022.104185_bib0027) 2017; 5 Lamers (10.1016/j.ebiom.2022.104185_bib0081) 2021; 40 Gagiannis (10.1016/j.ebiom.2022.104185_bib0009) 2020; 11 Carson (10.1016/j.ebiom.2022.104185_bib0025) 1994; 180 Bonaventura (10.1016/j.ebiom.2022.104185_bib0084) 2021; 21 Wu (10.1016/j.ebiom.2022.104185_bib0047) 2021; 9 Verheyden (10.1016/j.ebiom.2022.104185_bib0096) 2020; 22 D'Agnillo (10.1016/j.ebiom.2022.104185_bib0130) 2021; 13 Jia (10.1016/j.ebiom.2022.104185_bib0102) 2016; 46 Barkauskas (10.1016/j.ebiom.2022.104185_bib0091) 2013; 123 Tindle (10.1016/j.ebiom.2022.104185_bib0028) 2021; 10 van der Meer (10.1016/j.ebiom.2022.104185_bib0052) 2010; 51 Strunz (10.1016/j.ebiom.2022.104185_bib0068) 2020; 11 Sahoo (10.1016/j.ebiom.2022.104185_bib0019) 2007; 35 Reyfman (10.1016/j.ebiom.2022.104185_bib0044) 2019; 199 Lopez-Sanchez (10.1016/j.ebiom.2022.104185_bib0029) 2014; 5 Bermejo-Martin (10.1016/j.ebiom.2022.104185_bib0053) 2010; 14 Sodhi (10.1016/j.ebiom.2022.104185_bib0101) 2019; 203 Marshall (10.1016/j.ebiom.2022.104185_bib0048) 2020; 585 Froidure (10.1016/j.ebiom.2022.104185_bib0118) 2020; 12 Esposito (10.1016/j.ebiom.2022.104185_bib0104) 2020; 202 Abdelnabi (10.1016/j.ebiom.2022.104185_bib0071) 2021; 72 Pang (10.1016/j.ebiom.2022.104185_bib0080) 2021; 12 Gangwar (10.1016/j.ebiom.2022.104185_bib0041) 2017; 7 Frank (10.1016/j.ebiom.2022.104185_bib0092) 2016; 17 Wagstaffe (10.1016/j.ebiom.2022.104185_bib0023) 2019; 203 10.1016/j.ebiom.2022.104185_bib0082 McGroder (10.1016/j.ebiom.2022.104185_bib0119) 2021; 76 Spagnolo (10.1016/j.ebiom.2022.104185_bib0001) 2020; 8 Barrett (10.1016/j.ebiom.2022.104185_bib0083) 2021; 7 Ju (10.1016/j.ebiom.2022.104185_bib0134) 2007; 13 Szklarczyk (10.1016/j.ebiom.2022.104185_bib0021) 2021; 49 van Gassel (10.1016/j.ebiom.2022.104185_bib0011) 2021; 49 Cheon (10.1016/j.ebiom.2022.104185_bib0014) 2021; 6 Schneider (10.1016/j.ebiom.2022.104185_bib0117) 2014; 32 Xi (10.1016/j.ebiom.2022.104185_bib0110) 2020; 6 Sanchez-Vazquez (10.1016/j.ebiom.2022.104185_bib0094) 2021; 13 34873597 - bioRxiv. 2022 Jul 18:2021.11.28.470269. doi: 10.1101/2021.11.28.470269 |
References_xml | – volume: 10 start-page: 611 year: 2021 ident: bib0016 article-title: Emergency lung transplantation after COVID-19: immunopathological insights on two affected patients publication-title: Cells – volume: 203 start-page: 707 year: 2021 end-page: 717 ident: bib0070 article-title: Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis publication-title: Am J Respir Crit Care Med – volume: 70 year: 2021 ident: bib0095 article-title: Short telomeres and severe COVID-19: the connection conundrum publication-title: EBioMedicine – volume: 22 start-page: 934 year: 2020 end-page: 946 ident: bib0069 article-title: Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis publication-title: Nat Cell Biol – volume: 112 start-page: 5099 year: 2015 end-page: 5104 ident: bib0115 article-title: Telomere dysfunction causes alveolar stem cell failure publication-title: Proc Natl Acad Sci USA – volume: 10 start-page: e224 year: 2020 ident: bib0046 article-title: Persistent viral activity, cytokine storm, and lung fibrosis in a case of severe COVID-19 publication-title: Clin Transl Med – volume: 10 start-page: 531 year: 2019 ident: bib0063 article-title: SCINA: a semi-supervised subtyping algorithm of single cells and bulk samples publication-title: Genes (Basel) – volume: 11 start-page: eaax5866 year: 2019 ident: bib0074 article-title: Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia publication-title: Sci Transl Med – volume: 108 start-page: 970 year: 2001 end-page: 975 ident: bib0112 article-title: Expression of IL-15 in inflammatory pulmonary diseases publication-title: J Allergy Clin Immunol – volume: 22 start-page: 6151 year: 2021 ident: bib0120 article-title: Evidence for biological age acceleration and telomere shortening in COVID-19 survivors publication-title: Int J Mol Sci – volume: 52 start-page: 130 year: 2020 end-page: 151 ident: bib0125 article-title: TGF-β1/IL-11/MEK/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency publication-title: Exp Mol Med – volume: 9 start-page: 1178 year: 2020 ident: bib0050 article-title: Severe fatigue is highly prevalent in patients with IPF or sarcoidosis publication-title: J Clin Med – volume: 19 year: 2020 ident: bib0111 article-title: The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease publication-title: Autoimmun Rev – volume: 9 start-page: 487 year: 2021 end-page: 497 ident: bib0017 article-title: Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries publication-title: Lancet Respir Med – volume: 12 start-page: eabb5883 year: 2020 ident: bib0075 article-title: An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice publication-title: Sci Transl Med – volume: 10 year: 2015 ident: bib0024 article-title: A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccination publication-title: PLoS One – volume: 68 year: 2021 ident: bib0018 article-title: AI-guided discovery of the invariant host response to viral pandemics publication-title: EBioMedicine – volume: 5 start-page: 857 year: 2017 end-page: 868 ident: bib0027 article-title: Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study publication-title: Lancet Respir Med – year: 2022 ident: bib0127 article-title: Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis publication-title: Eur Respir J – volume: 54 start-page: 259 year: 2021 end-page: 275 ident: bib0061 article-title: Distinct developmental pathways from blood monocytes generate human lung macrophage diversity publication-title: Immunity – volume: 66 start-page: 107 year: 2021 end-page: 111 ident: bib0129 article-title: Evidence that SARS-CoV-2 induces lung-cell senescence: potential impact on COVID-19 lung disease publication-title: Am J Respir Cell Mol Biol – volume: 12 start-page: 19911 year: 2020 end-page: 19922 ident: bib0118 article-title: Short telomeres increase the risk of severe COVID-19 publication-title: Aging (Albany NY) – volume: 11 start-page: 3559 year: 2020 ident: bib0068 article-title: Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis publication-title: Nat Commun – volume: 40 year: 2021 ident: bib0081 article-title: An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells publication-title: EMBO J – volume: 4 start-page: 70 year: 2011 ident: bib0039 article-title: Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle publication-title: BMC Med Genomics – volume: 4 start-page: 7027 year: 2014 ident: bib0078 article-title: Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury publication-title: Sci Rep – volume: 13 start-page: 742 year: 2007 end-page: 747 ident: bib0134 article-title: Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment publication-title: Nat Med – volume: 56 start-page: 1 year: 2020 end-page: 9 ident: bib0006 article-title: Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: a narrative review publication-title: Can J Respir Ther – volume: 40 start-page: 1823 year: 2020 end-page: 1838 ident: bib0008 article-title: Residual lung injury in patients recovering from COVID-19 critical illness: a prospective longitudinal point-of-care lung ultrasound study publication-title: J Ultrasound Med – reference: Lee IY, Ho JM, Chen MS. CLUGO: a clustering algorithm for automated functional annotations based on gene ontology. In Fifth IEEE International Conference on Data Mining (ICDM'05) 2005 Nov 27 (pp. 4-pp). IEEE. – volume: 17 start-page: 779 year: 2011 end-page: 787 ident: bib0033 article-title: Quantification of collagen organization and extracellular matrix factors within the healing ligament publication-title: Microsc Microanal – volume: 199 start-page: 1517 year: 2019 end-page: 1536 ident: bib0044 article-title: Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis publication-title: Am J Respir Crit Care Med – volume: 3 start-page: 24 year: 2021 end-page: 26 ident: bib0109 article-title: Usefulness of pirfenidone in covid lung: a case series publication-title: Eur J Med Health Sci – volume: 13 start-page: 2687 year: 2022 ident: bib0035 article-title: An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease publication-title: Nat Commun – volume: 132 year: 2020 ident: bib0097 article-title: Cell senescence and fibrotic lung diseases publication-title: Exp Gerontol – volume: 202 start-page: 1656 year: 2020 end-page: 1665 ident: bib0105 article-title: Outcome of Hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study publication-title: Am J Respir Crit Care Med – volume: 72 year: 2021 ident: bib0071 article-title: The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model publication-title: EBioMedicine – volume: 23 start-page: e01041 year: 2021 ident: bib0007 article-title: Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection publication-title: IDCases – volume: 27 start-page: 366 year: 2020 end-page: 382 ident: bib0067 article-title: Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration publication-title: Cell Stem Cell – volume: 9 start-page: e96801 year: 2014 ident: bib0032 article-title: IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples publication-title: PLoS One – volume: 49 start-page: D605 year: 2021 end-page: D612 ident: bib0021 article-title: The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets publication-title: Nucleic Acids Res – volume: 6 year: 2021 ident: bib0014 article-title: Immune signatures underlying post-acute COVID-19 lung sequelae publication-title: Sci Immunol – volume: 18 start-page: 773 year: 2021 end-page: 774 ident: bib0004 article-title: Lungs after COVID-19: evolving knowledge of post-COVID-19 interstitial lung disease publication-title: Ann Am Thorac Soc – volume: 22 start-page: 6214 year: 2021 ident: bib0098 article-title: Cellular senescence: pathogenic mechanisms in lung fibrosis publication-title: Int J Mol Sci – volume: 10 start-page: 3150 year: 2019 ident: bib0087 article-title: Crucial involvement of IL-6 in thrombus resolution in mice via macrophage recruitment and the induction of proteolytic enzymes publication-title: Front Immunol – volume: 30 start-page: 1770 year: 2019 end-page: 1779 ident: bib0133 article-title: Unbiased Boolean analysis of public gene expression data for cell cycle gene identification publication-title: Mol Biol Cell – volume: 180 start-page: 1395 year: 1994 end-page: 1403 ident: bib0025 article-title: Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor publication-title: J Exp Med – volume: 49 year: 2021 ident: bib0011 article-title: Functional outcomes and their association with physical performance in mechanically ventilated coronavirus disease 2019 survivors at 3 months following hospital discharge: a cohort study publication-title: Crit Care Med – volume: 353 start-page: 1374 year: 2005 end-page: 1385 ident: bib0056 article-title: Avian influenza A (H5N1) infection in humans publication-title: N Engl J Med – volume: 585 start-page: 339 year: 2020 end-page: 341 ident: bib0048 article-title: The lasting misery of coronavirus long-haulers publication-title: Nature – volume: 7 start-page: 1554 year: 2017 ident: bib0041 article-title: Detecting the molecular system signatures of idiopathic pulmonary fibrosis through integrated genomic analysis publication-title: Sci Rep – volume: 202 start-page: 1614 year: 2020 end-page: 1616 ident: bib0106 article-title: COVID-19 and interstitial lung disease: keep them separate publication-title: Am J Respir Crit Care Med – volume: 599 start-page: 283 year: 2021 end-page: 289 ident: bib0128 article-title: Virus-induced senescence is a driver and therapeutic target in COVID-19 publication-title: Nature – volume: 14 start-page: 14 year: 2020 end-page: 16 ident: bib0108 article-title: Clinical improvement with pirfenidone in two patients of COVID 19 publication-title: J Clin Diagnostic Res – volume: 35 start-page: 3705 year: 2007 end-page: 3712 ident: bib0019 article-title: Extracting binary signals from microarray time-course data publication-title: Nucleic Acids Res – volume: 203 start-page: 1609 year: 2019 end-page: 1618 ident: bib0023 article-title: Influenza vaccination primes human myeloid cell cytokine secretion and NK cell function publication-title: J Immunol – volume: 9 start-page: 747 year: 2021 end-page: 754 ident: bib0047 article-title: 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study publication-title: Lancet Respir Med – volume: 52 start-page: 217 year: 2015 end-page: 231 ident: bib0040 article-title: A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis publication-title: Am J Respir Cell Mol Biol – volume: 13 start-page: eabj7790 year: 2021 ident: bib0130 article-title: Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19 publication-title: Sci Transl Med – volume: 202 start-page: 1710 year: 2020 end-page: 1713 ident: bib0104 article-title: Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control Study publication-title: Am J Respir Crit Care Med – volume: 212 start-page: 681 year: 2015 end-page: 697 ident: bib0060 article-title: TREM-2 promotes macrophage survival and lung disease after respiratory viral infection publication-title: J Exp Med – volume: 9 start-page: R85 year: 2007 ident: bib0114 article-title: Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease publication-title: Arthritis Res Ther – volume: 22 start-page: 484 year: 2016 end-page: 491 ident: bib0037 article-title: From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis publication-title: Curr Opin Pulm Med – volume: 8 start-page: 807 year: 2020 end-page: 815 ident: bib0010 article-title: Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy publication-title: Lancet Respir Med – volume: 11 year: 2015 ident: bib0058 article-title: Host transcriptional response to influenza and other acute respiratory viral infections–a prospective cohort study publication-title: PLoS Pathog – volume: 12 year: 2020 ident: bib0015 article-title: Lung transplantation for patients with severe COVID-19 publication-title: Sci Transl Med – volume: 183 start-page: 173 year: 2013 end-page: 181 ident: bib0086 article-title: Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis publication-title: Am J Pathol – volume: 108 start-page: E1475 year: 2011 end-page: E1483 ident: bib0090 article-title: Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition publication-title: Proc Natl Acad Sci USA – volume: 46 start-page: D649 year: 2018 end-page: DD55 ident: bib0020 article-title: The reactome pathway knowledgebase publication-title: Nucleic Acids Res – volume: 13 start-page: e12501 year: 2021 ident: bib0005 article-title: Restrictive lung disease in patients with subclinical coronavirus infection: are we bracing ourselves for devastating sequelae? publication-title: Cureus – volume: 96 start-page: 2578 year: 1995 end-page: 2582 ident: bib0026 article-title: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro publication-title: J Clin Invest – volume: 76 start-page: 1242 year: 2021 end-page: 1245 ident: bib0119 article-title: Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length publication-title: Thorax – volume: 20 start-page: 2557 year: 2020 end-page: 2560 ident: bib0079 article-title: Pulmonary fibrosis in the aftermath of the COVID-19 era (Review) publication-title: Exp Ther Med – volume: 13 start-page: 224 year: 2014 end-page: 234 ident: bib0099 article-title: ACE and ACE2 in inflammation: a tale of two enzymes publication-title: Inflamm Allergy Drug Targets – volume: 17 start-page: 2312 year: 2016 end-page: 2325 ident: bib0092 article-title: Emergence of a wave of wnt signaling that regulates lung alveologenesis by controlling epithelial self-renewal and differentiation publication-title: Cell Rep – volume: 51 start-page: 56 year: 2010 end-page: 62 ident: bib0052 article-title: The new influenza A H1N1 virus: balancing on the interface of humans and animals publication-title: Can Vet J – volume: 13 start-page: 197 year: 2014 end-page: 200 ident: bib0093 article-title: Endoplasmic reticulum stress activates telomerase publication-title: Aging Cell – volume: 12 start-page: 3309 year: 2021 ident: bib0030 article-title: Drug repurposing screens identify chemical entities for the development of COVID-19 interventions publication-title: Nat Commun – volume: 378 start-page: 1811 year: 2018 end-page: 1823 ident: bib0043 article-title: Idiopathic pulmonary fibrosis publication-title: N Engl J Med – volume: 22 start-page: 1025 year: 2020 end-page: 1026 ident: bib0096 article-title: A transitional stem cell state in the lung publication-title: Nat Cell Biol – volume: 23 start-page: 2376 year: 2009 end-page: 2381 ident: bib0100 article-title: Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development publication-title: Genes Dev – volume: 32 start-page: 513 year: 2014 end-page: 545 ident: bib0117 article-title: Interferon-stimulated genes: a complex web of host defenses publication-title: Annu Rev Immunol – volume: 13 start-page: 1 year: 2021 end-page: 15 ident: bib0094 article-title: Shorter telomere lengths in patients with severe COVID-19 disease publication-title: Aging (Albany NY) – volume: 1 start-page: e90558 year: 2016 ident: bib0123 article-title: Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis publication-title: JCI Insight – volume: 10 start-page: e66417 year: 2021 ident: bib0028 article-title: Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19 publication-title: Elife – volume: 18 start-page: 799 year: 2021 end-page: 806 ident: bib0002 article-title: Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment publication-title: Ann Am Thorac Soc – volume: 206 start-page: 167 year: 2012 end-page: 177 ident: bib0116 article-title: Critical role of natural killer cells in lung immunopathology during influenza infection in mice publication-title: J Infect Dis – volume: 218 start-page: 16 year: 2020 end-page: 28 ident: bib0073 article-title: Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model publication-title: Transl Res – volume: 6 start-page: eaba1983 year: 2020 ident: bib0045 article-title: Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis publication-title: Sci Adv – volume: 6 start-page: 051 year: 2020 end-page: 053 ident: bib0110 article-title: Post-inflammatory pulmonary fibrosis in a discharged COVID-19 patient: Effectively treated with Pirfenidone publication-title: Archives of Pulmonology and Respiratory Care – volume: 10 start-page: 362 year: 2013 end-page: 370 ident: bib0038 article-title: Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes publication-title: Ann Am Thorac Soc – volume: 203 start-page: 3000 year: 2019 end-page: 3012 ident: bib0101 article-title: A dynamic variation of pulmonary ACE2 is required to modulate neutrophilic inflammation in response to publication-title: J Immunol – volume: 369 start-page: 956 year: 2020 end-page: 963 ident: bib0031 article-title: Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model publication-title: Science – volume: 6 start-page: 11 year: 2021 end-page: 18 ident: bib0072 article-title: Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets publication-title: Nat Microbiol – volume: 22 start-page: 5131 year: 2021 ident: bib0085 article-title: Pathophysiological association of endothelial dysfunction with fatal outcome in COVID-19 publication-title: Int J Mol Sci – volume: 201 start-page: 198 year: 2020 end-page: 211 ident: bib0121 article-title: Grp78 loss in epithelial progenitors reveals an age-linked role for endoplasmic reticulum stress in pulmonary fibrosis publication-title: Am J Respir Crit Care Med – volume: 360 start-page: 2666 year: 2009 end-page: 2667 ident: bib0054 article-title: H1N1 influenza A disease–information for health professionals publication-title: N Engl J Med – volume: 201 start-page: 198 year: 2020 end-page: 211 ident: bib0089 article-title: Loss in epithelial progenitors reveals an age-linked role for endoplasmic reticulum stress in pulmonary fibrosis publication-title: Am J Respir Crit Care Med – volume: 62 start-page: 319 year: 2020 end-page: 330 ident: bib0126 article-title: PAI-1 regulation of TGF-β1-induced alveolar type II cell senescence, SASP secretion, and SASP-mediated activation of alveolar macrophages publication-title: Am J Respir Cell Mol Biol – volume: 5 start-page: 4451 year: 2014 ident: bib0029 article-title: GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis publication-title: Nat Commun – volume: 21 start-page: 319 year: 2021 end-page: 329 ident: bib0084 article-title: Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 publication-title: Nat Rev Immunol – volume: 8 start-page: 750 year: 2020 end-page: 752 ident: bib0001 article-title: Pulmonary fibrosis secondary to COVID-19: a call to arms? publication-title: Lancet Respir Med – volume: 8 year: 2020 ident: bib0049 article-title: Fatigue in idiopathic pulmonary fibrosis measured by the fatigue assessment scale during antifibrotic treatment publication-title: Eur Clin Respir J – volume: 107 start-page: 5732 year: 2010 end-page: 5737 ident: bib0132 article-title: MiDReG: a method of mining developmentally regulated genes using Boolean implications publication-title: Proc Natl Acad Sci USA – volume: 436 start-page: 112 year: 2005 end-page: 116 ident: bib0036 article-title: Angiotensin-converting enzyme 2 protects from severe acute lung failure publication-title: Nature – volume: 7 start-page: d1743 year: 2002 end-page: d1761 ident: bib0066 article-title: Molecular mechanisms of pulmonary fibrosis publication-title: Front Biosci – volume: 77 start-page: 301 year: 2013 end-page: 308 ident: bib0103 article-title: Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases publication-title: Circ J – volume: 13 start-page: 4872 year: 2021 end-page: 4884 ident: bib0051 article-title: Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis publication-title: J Thorac Dis – volume: 386 start-page: 509 year: 2022 end-page: 520 ident: bib0077 article-title: Molnupiravir for oral treatment of covid-19 in nonhospitalized patients publication-title: N Engl J Med – volume: 11 year: 2020 ident: bib0009 article-title: Clinical, serological, and histopathological similarities between severe COVID-19 and acute exacerbation of connective tissue disease-associated interstitial lung disease (CTD-ILD) publication-title: Front Immunol – year: 2020 ident: bib0022 article-title: Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil publication-title: BMJ Evid Based Med – volume: 128 start-page: 36 year: 2018 end-page: 44 ident: bib0065 article-title: Insights from human genetic studies of lung and organ fibrosis publication-title: J Clin Invest – volume: 141 start-page: 7 year: 2018 end-page: 13 ident: bib0113 article-title: Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody publication-title: Respir Med – volume: 46 start-page: 239 year: 2016 end-page: 248 ident: bib0102 article-title: Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease publication-title: Shock – volume: 14 start-page: R167 year: 2010 ident: bib0053 article-title: Host adaptive immunity deficiency in severe pandemic influenza publication-title: Crit Care – volume: 9 start-page: R157 year: 2008 ident: bib0131 article-title: Boolean implication networks derived from large scale, whole genome microarray datasets publication-title: Genome Biol – volume: 299 start-page: E216 year: 2021 end-page: e8 ident: bib0003 article-title: Interstitial lung disease after COVID-19 infection: a catalog of uncertainties publication-title: Radiology – volume: 130 start-page: 5088 year: 2020 end-page: 5099 ident: bib0088 article-title: Contributions of alveolar epithelial cell quality control to pulmonary fibrosis publication-title: J Clin Invest – volume: 26 start-page: 842 year: 2020 end-page: 844 ident: bib0059 article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 publication-title: Nat Med – volume: 2011 year: 2011 ident: bib0012 article-title: Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disorders publication-title: Pulm Med – volume: 367 start-page: 1814 year: 2012 end-page: 1820 ident: bib0057 article-title: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia publication-title: N Engl J Med – volume: 14 year: 2019 ident: bib0034 article-title: Histochemical quantification of collagen content in articular cartilage publication-title: PLoS One – volume: 7 start-page: eabh2434 year: 2021 ident: bib0083 article-title: Platelets amplify endotheliopathy in COVID-19 publication-title: Sci Adv – volume: 383 start-page: 120 year: 2020 end-page: 128 ident: bib0013 article-title: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 publication-title: N Engl J Med – volume: 21 start-page: 2269 year: 2020 ident: bib0064 article-title: Alveolar epithelial type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis publication-title: Int J Mol Sci – volume: 47 start-page: 212 year: 2016 end-page: 222 ident: bib0062 article-title: Interleukin-15 is associated with disease severity in viral bronchiolitis publication-title: Eur Respir J – volume: 22 start-page: 1285 year: 2016 end-page: 1293 ident: bib0122 article-title: Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice publication-title: Nat Med – volume: 162 start-page: 156 year: 2013 end-page: 173 ident: bib0124 article-title: Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema publication-title: Transl Res – volume: 123 start-page: 3025 year: 2013 end-page: 3036 ident: bib0091 article-title: Type 2 alveolar cells are stem cells in adult lung publication-title: J Clin Invest – volume: 12 start-page: 814 year: 2021 ident: bib0080 article-title: Efficacy and tolerability of bevacizumab in patients with severe Covid-19 publication-title: Nat Commun – volume: 92 start-page: e01965 year: 2018 end-page: 17 ident: bib0076 article-title: β-d-N (4)-hydroxycytidine is a potent anti-alphavirus compound that induces a high level of mutations in the viral genome publication-title: J Virol – volume: 203 start-page: 245 year: 2021 end-page: 249 ident: bib0107 article-title: Risk factors for mortality after COVID-19 in patients with preexisting interstitial lung disease publication-title: Am J Respir Crit Care Med – volume: 14 year: 2019 ident: bib0042 article-title: A robust data-driven genomic signature for idiopathic pulmonary fibrosis with applications for translational model selection publication-title: PLoS One – volume: 362 start-page: 1353 year: 2003 end-page: 1358 ident: bib0055 article-title: Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003 publication-title: Lancet – volume: 27 start-page: 366 issue: 3 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0067 article-title: Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration publication-title: Cell Stem Cell doi: 10.1016/j.stem.2020.06.020 – volume: 70 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0095 article-title: Short telomeres and severe COVID-19: the connection conundrum publication-title: EBioMedicine doi: 10.1016/j.ebiom.2021.103513 – volume: 203 start-page: 1609 issue: 6 year: 2019 ident: 10.1016/j.ebiom.2022.104185_bib0023 article-title: Influenza vaccination primes human myeloid cell cytokine secretion and NK cell function publication-title: J Immunol doi: 10.4049/jimmunol.1801648 – volume: 12 start-page: 3309 issue: 1 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0030 article-title: Drug repurposing screens identify chemical entities for the development of COVID-19 interventions publication-title: Nat Commun doi: 10.1038/s41467-021-23328-0 – volume: 436 start-page: 112 issue: 7047 year: 2005 ident: 10.1016/j.ebiom.2022.104185_bib0036 article-title: Angiotensin-converting enzyme 2 protects from severe acute lung failure publication-title: Nature doi: 10.1038/nature03712 – volume: 12 start-page: 814 issue: 1 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0080 article-title: Efficacy and tolerability of bevacizumab in patients with severe Covid-19 publication-title: Nat Commun doi: 10.1038/s41467-021-21085-8 – volume: 378 start-page: 1811 issue: 19 year: 2018 ident: 10.1016/j.ebiom.2022.104185_bib0043 article-title: Idiopathic pulmonary fibrosis publication-title: N Engl J Med doi: 10.1056/NEJMra1705751 – volume: 17 start-page: 779 issue: 5 year: 2011 ident: 10.1016/j.ebiom.2022.104185_bib0033 article-title: Quantification of collagen organization and extracellular matrix factors within the healing ligament publication-title: Microsc Microanal doi: 10.1017/S1431927611011925 – volume: 386 start-page: 509 issue: 6 year: 2022 ident: 10.1016/j.ebiom.2022.104185_bib0077 article-title: Molnupiravir for oral treatment of covid-19 in nonhospitalized patients publication-title: N Engl J Med doi: 10.1056/NEJMoa2116044 – volume: 9 start-page: R157 issue: 10 year: 2008 ident: 10.1016/j.ebiom.2022.104185_bib0131 article-title: Boolean implication networks derived from large scale, whole genome microarray datasets publication-title: Genome Biol doi: 10.1186/gb-2008-9-10-r157 – volume: 5 start-page: 857 issue: 11 year: 2017 ident: 10.1016/j.ebiom.2022.104185_bib0027 article-title: Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(17)30349-1 – volume: 47 start-page: 212 issue: 1 year: 2016 ident: 10.1016/j.ebiom.2022.104185_bib0062 article-title: Interleukin-15 is associated with disease severity in viral bronchiolitis publication-title: Eur Respir J doi: 10.1183/13993003.00642-2015 – volume: 10 start-page: 3150 year: 2019 ident: 10.1016/j.ebiom.2022.104185_bib0087 article-title: Crucial involvement of IL-6 in thrombus resolution in mice via macrophage recruitment and the induction of proteolytic enzymes publication-title: Front Immunol doi: 10.3389/fimmu.2019.03150 – volume: 202 start-page: 1710 issue: 12 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0104 article-title: Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control Study publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.202006-2441LE – volume: 62 start-page: 319 issue: 3 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0126 article-title: PAI-1 regulation of TGF-β1-induced alveolar type II cell senescence, SASP secretion, and SASP-mediated activation of alveolar macrophages publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2019-0071OC – volume: 128 start-page: 36 issue: 1 year: 2018 ident: 10.1016/j.ebiom.2022.104185_bib0065 article-title: Insights from human genetic studies of lung and organ fibrosis publication-title: J Clin Invest doi: 10.1172/JCI93556 – volume: 54 start-page: 259 issue: 2 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0061 article-title: Distinct developmental pathways from blood monocytes generate human lung macrophage diversity publication-title: Immunity doi: 10.1016/j.immuni.2020.12.003 – volume: 68 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0018 article-title: AI-guided discovery of the invariant host response to viral pandemics publication-title: EBioMedicine doi: 10.1016/j.ebiom.2021.103390 – volume: 10 start-page: 611 issue: 3 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0016 article-title: Emergency lung transplantation after COVID-19: immunopathological insights on two affected patients publication-title: Cells doi: 10.3390/cells10030611 – volume: 35 start-page: 3705 issue: 11 year: 2007 ident: 10.1016/j.ebiom.2022.104185_bib0019 article-title: Extracting binary signals from microarray time-course data publication-title: Nucleic Acids Res doi: 10.1093/nar/gkm284 – volume: 9 start-page: 1178 issue: 4 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0050 article-title: Severe fatigue is highly prevalent in patients with IPF or sarcoidosis publication-title: J Clin Med doi: 10.3390/jcm9041178 – volume: 212 start-page: 681 issue: 5 year: 2015 ident: 10.1016/j.ebiom.2022.104185_bib0060 article-title: TREM-2 promotes macrophage survival and lung disease after respiratory viral infection publication-title: J Exp Med doi: 10.1084/jem.20141732 – volume: 112 start-page: 5099 issue: 16 year: 2015 ident: 10.1016/j.ebiom.2022.104185_bib0115 article-title: Telomere dysfunction causes alveolar stem cell failure publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1504780112 – volume: 13 start-page: 224 issue: 4 year: 2014 ident: 10.1016/j.ebiom.2022.104185_bib0099 article-title: ACE and ACE2 in inflammation: a tale of two enzymes publication-title: Inflamm Allergy Drug Targets doi: 10.2174/1871528113666140713164506 – volume: 383 start-page: 120 issue: 2 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0013 article-title: Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19 publication-title: N Engl J Med doi: 10.1056/NEJMoa2015432 – volume: 8 issue: 1 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0049 article-title: Fatigue in idiopathic pulmonary fibrosis measured by the fatigue assessment scale during antifibrotic treatment publication-title: Eur Clin Respir J doi: 10.1080/20018525.2020.1853658 – volume: 22 start-page: 6151 issue: 11 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0120 article-title: Evidence for biological age acceleration and telomere shortening in COVID-19 survivors publication-title: Int J Mol Sci doi: 10.3390/ijms22116151 – volume: 10 start-page: 362 issue: 4 year: 2013 ident: 10.1016/j.ebiom.2022.104185_bib0038 article-title: Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes publication-title: Ann Am Thorac Soc doi: 10.1513/AnnalsATS.201303-069FR – volume: 13 start-page: 1 issue: 1 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0094 article-title: Shorter telomere lengths in patients with severe COVID-19 disease publication-title: Aging (Albany NY) doi: 10.18632/aging.202463 – volume: 11 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0009 article-title: Clinical, serological, and histopathological similarities between severe COVID-19 and acute exacerbation of connective tissue disease-associated interstitial lung disease (CTD-ILD) publication-title: Front Immunol doi: 10.3389/fimmu.2020.587517 – volume: 3 start-page: 24 issue: 1 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0109 article-title: Usefulness of pirfenidone in covid lung: a case series publication-title: Eur J Med Health Sci doi: 10.24018/ejmed.2021.3.1.670 – volume: 13 start-page: 742 issue: 6 year: 2007 ident: 10.1016/j.ebiom.2022.104185_bib0134 article-title: Telomere dysfunction induces environmental alterations limiting hematopoietic stem cell function and engraftment publication-title: Nat Med doi: 10.1038/nm1578 – ident: 10.1016/j.ebiom.2022.104185_bib0082 – volume: 22 start-page: 484 issue: 5 year: 2016 ident: 10.1016/j.ebiom.2022.104185_bib0037 article-title: From granuloma to fibrosis: sarcoidosis associated pulmonary fibrosis publication-title: Curr Opin Pulm Med doi: 10.1097/MCP.0000000000000301 – volume: 13 start-page: 4872 issue: 8 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0051 article-title: Perceptions of fatigue in patients with idiopathic pulmonary fibrosis or sarcoidosis publication-title: J Thorac Dis doi: 10.21037/jtd-21-462 – volume: 360 start-page: 2666 issue: 25 year: 2009 ident: 10.1016/j.ebiom.2022.104185_bib0054 article-title: H1N1 influenza A disease–information for health professionals publication-title: N Engl J Med doi: 10.1056/NEJMe0903992 – volume: 203 start-page: 245 issue: 2 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0107 article-title: Risk factors for mortality after COVID-19 in patients with preexisting interstitial lung disease publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.202007-2638LE – volume: 299 start-page: E216 issue: 1 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0003 article-title: Interstitial lung disease after COVID-19 infection: a catalog of uncertainties publication-title: Radiology doi: 10.1148/radiol.2021204482 – volume: 201 start-page: 198 issue: 2 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0121 article-title: Grp78 loss in epithelial progenitors reveals an age-linked role for endoplasmic reticulum stress in pulmonary fibrosis publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201902-0451OC – volume: 13 start-page: e12501 issue: 1 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0005 article-title: Restrictive lung disease in patients with subclinical coronavirus infection: are we bracing ourselves for devastating sequelae? publication-title: Cureus – volume: 362 start-page: 1353 issue: 9393 year: 2003 ident: 10.1016/j.ebiom.2022.104185_bib0055 article-title: Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003 publication-title: Lancet doi: 10.1016/S0140-6736(03)14630-2 – volume: 12 start-page: eabb5883 issue: 541 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0075 article-title: An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice publication-title: Sci Transl Med doi: 10.1126/scitranslmed.abb5883 – volume: 4 start-page: 7027 year: 2014 ident: 10.1016/j.ebiom.2022.104185_bib0078 article-title: Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury publication-title: Sci Rep doi: 10.1038/srep07027 – volume: 9 start-page: e96801 issue: 5 year: 2014 ident: 10.1016/j.ebiom.2022.104185_bib0032 article-title: IHC Profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples publication-title: PLoS One doi: 10.1371/journal.pone.0096801 – volume: 18 start-page: 799 issue: 5 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0002 article-title: Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment publication-title: Ann Am Thorac Soc doi: 10.1513/AnnalsATS.202008-1002OC – volume: 183 start-page: 173 issue: 1 year: 2013 ident: 10.1016/j.ebiom.2022.104185_bib0086 article-title: Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis publication-title: Am J Pathol doi: 10.1016/j.ajpath.2013.03.014 – volume: 7 start-page: eabh2434 issue: 37 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0083 article-title: Platelets amplify endotheliopathy in COVID-19 publication-title: Sci Adv doi: 10.1126/sciadv.abh2434 – volume: 49 start-page: D605 issue: D1 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0021 article-title: The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets publication-title: Nucleic Acids Res doi: 10.1093/nar/gkaa1074 – volume: 6 start-page: 11 issue: 1 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0072 article-title: Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets publication-title: Nat Microbiol doi: 10.1038/s41564-020-00835-2 – volume: 6 start-page: 051 issue: 1 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0110 article-title: Post-inflammatory pulmonary fibrosis in a discharged COVID-19 patient: Effectively treated with Pirfenidone publication-title: Archives of Pulmonology and Respiratory Care – volume: 202 start-page: 1656 issue: 12 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0105 article-title: Outcome of Hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.202007-2794OC – volume: 4 start-page: 70 year: 2011 ident: 10.1016/j.ebiom.2022.104185_bib0039 article-title: Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle publication-title: BMC Med Genomics doi: 10.1186/1755-8794-4-70 – volume: 32 start-page: 513 year: 2014 ident: 10.1016/j.ebiom.2022.104185_bib0117 article-title: Interferon-stimulated genes: a complex web of host defenses publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-032713-120231 – volume: 206 start-page: 167 issue: 2 year: 2012 ident: 10.1016/j.ebiom.2022.104185_bib0116 article-title: Critical role of natural killer cells in lung immunopathology during influenza infection in mice publication-title: J Infect Dis doi: 10.1093/infdis/jis340 – volume: 201 start-page: 198 issue: 2 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0089 article-title: Loss in epithelial progenitors reveals an age-linked role for endoplasmic reticulum stress in pulmonary fibrosis publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201902-0451OC – year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0022 article-title: Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil publication-title: BMJ Evid Based Med – volume: 40 start-page: 1823 issue: 9 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0008 article-title: Residual lung injury in patients recovering from COVID-19 critical illness: a prospective longitudinal point-of-care lung ultrasound study publication-title: J Ultrasound Med doi: 10.1002/jum.15563 – volume: 72 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0071 article-title: The combined treatment of Molnupiravir and Favipiravir results in a potentiation of antiviral efficacy in a SARS-CoV-2 hamster infection model publication-title: EBioMedicine doi: 10.1016/j.ebiom.2021.103595 – volume: 130 start-page: 5088 issue: 10 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0088 article-title: Contributions of alveolar epithelial cell quality control to pulmonary fibrosis publication-title: J Clin Invest doi: 10.1172/JCI139519 – volume: 107 start-page: 5732 issue: 13 year: 2010 ident: 10.1016/j.ebiom.2022.104185_bib0132 article-title: MiDReG: a method of mining developmentally regulated genes using Boolean implications publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0913635107 – volume: 6 issue: 65 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0014 article-title: Immune signatures underlying post-acute COVID-19 lung sequelae publication-title: Sci Immunol doi: 10.1126/sciimmunol.abk1741 – volume: 20 start-page: 2557 issue: 3 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0079 article-title: Pulmonary fibrosis in the aftermath of the COVID-19 era (Review) publication-title: Exp Ther Med – volume: 22 start-page: 1285 issue: 11 year: 2016 ident: 10.1016/j.ebiom.2022.104185_bib0122 article-title: Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice publication-title: Nat Med doi: 10.1038/nm.4192 – volume: 66 start-page: 107 issue: 1 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0129 article-title: Evidence that SARS-CoV-2 induces lung-cell senescence: potential impact on COVID-19 lung disease publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2021-0205LE – volume: 9 start-page: 487 issue: 5 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0017 article-title: Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(21)00077-1 – volume: 22 start-page: 934 issue: 8 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0069 article-title: Persistence of a regeneration-associated, transitional alveolar epithelial cell state in pulmonary fibrosis publication-title: Nat Cell Biol doi: 10.1038/s41556-020-0542-8 – volume: 96 start-page: 2578 issue: 6 year: 1995 ident: 10.1016/j.ebiom.2022.104185_bib0026 article-title: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro publication-title: J Clin Invest doi: 10.1172/JCI118321 – volume: 8 start-page: 807 issue: 8 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0010 article-title: Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30225-3 – volume: 123 start-page: 3025 issue: 7 year: 2013 ident: 10.1016/j.ebiom.2022.104185_bib0091 article-title: Type 2 alveolar cells are stem cells in adult lung publication-title: J Clin Invest doi: 10.1172/JCI68782 – volume: 22 start-page: 5131 issue: 10 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0085 article-title: Pathophysiological association of endothelial dysfunction with fatal outcome in COVID-19 publication-title: Int J Mol Sci doi: 10.3390/ijms22105131 – volume: 13 start-page: 2687 issue: 1 year: 2022 ident: 10.1016/j.ebiom.2022.104185_bib0035 article-title: An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease publication-title: Nat Commun doi: 10.1038/s41467-022-30357-w – volume: 9 start-page: R85 issue: 5 year: 2007 ident: 10.1016/j.ebiom.2022.104185_bib0114 article-title: Serum IL-15 in patients with early systemic sclerosis: a potential novel marker of lung disease publication-title: Arthritis Res Ther doi: 10.1186/ar2284 – volume: 23 start-page: e01041 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0007 article-title: Post COVID-19 fibrosis, an emerging complicationof SARS-CoV-2 infection publication-title: IDCases doi: 10.1016/j.idcr.2020.e01041 – volume: 77 start-page: 301 issue: 2 year: 2013 ident: 10.1016/j.ebiom.2022.104185_bib0103 article-title: Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases publication-title: Circ J doi: 10.1253/circj.CJ-12-1544 – volume: 14 start-page: R167 issue: 5 year: 2010 ident: 10.1016/j.ebiom.2022.104185_bib0053 article-title: Host adaptive immunity deficiency in severe pandemic influenza publication-title: Crit Care doi: 10.1186/cc9259 – volume: 7 start-page: d1743 year: 2002 ident: 10.1016/j.ebiom.2022.104185_bib0066 article-title: Molecular mechanisms of pulmonary fibrosis publication-title: Front Biosci doi: 10.2741/pardo – volume: 218 start-page: 16 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0073 article-title: Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model publication-title: Transl Res doi: 10.1016/j.trsl.2019.12.002 – volume: 6 start-page: eaba1983 issue: 28 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0045 article-title: Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis publication-title: Sci Adv doi: 10.1126/sciadv.aba1983 – volume: 22 start-page: 6214 issue: 12 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0098 article-title: Cellular senescence: pathogenic mechanisms in lung fibrosis publication-title: Int J Mol Sci doi: 10.3390/ijms22126214 – volume: 11 issue: 6 year: 2015 ident: 10.1016/j.ebiom.2022.104185_bib0058 article-title: Host transcriptional response to influenza and other acute respiratory viral infections–a prospective cohort study publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1004869 – volume: 14 issue: 4 year: 2019 ident: 10.1016/j.ebiom.2022.104185_bib0042 article-title: A robust data-driven genomic signature for idiopathic pulmonary fibrosis with applications for translational model selection publication-title: PLoS One doi: 10.1371/journal.pone.0215565 – volume: 5 start-page: 4451 year: 2014 ident: 10.1016/j.ebiom.2022.104185_bib0029 article-title: GIV/Girdin is a central hub for profibrogenic signalling networks during liver fibrosis publication-title: Nat Commun doi: 10.1038/ncomms5451 – volume: 585 start-page: 339 issue: 7825 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0048 article-title: The lasting misery of coronavirus long-haulers publication-title: Nature doi: 10.1038/d41586-020-02598-6 – volume: 180 start-page: 1395 issue: 4 year: 1994 ident: 10.1016/j.ebiom.2022.104185_bib0025 article-title: Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor publication-title: J Exp Med doi: 10.1084/jem.180.4.1395 – volume: 202 start-page: 1614 issue: 12 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0106 article-title: COVID-19 and interstitial lung disease: keep them separate publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.202010-3918ED – volume: 19 issue: 6 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0111 article-title: The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2020.102537 – volume: 162 start-page: 156 issue: 3 year: 2013 ident: 10.1016/j.ebiom.2022.104185_bib0124 article-title: Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema publication-title: Transl Res doi: 10.1016/j.trsl.2013.06.004 – volume: 12 issue: 574 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0015 article-title: Lung transplantation for patients with severe COVID-19 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.abe4282 – volume: 203 start-page: 3000 issue: 11 year: 2019 ident: 10.1016/j.ebiom.2022.104185_bib0101 article-title: A dynamic variation of pulmonary ACE2 is required to modulate neutrophilic inflammation in response to publication-title: J Immunol doi: 10.4049/jimmunol.1900579 – volume: 92 start-page: e01965 issue: 3 year: 2018 ident: 10.1016/j.ebiom.2022.104185_bib0076 article-title: β-d-N (4)-hydroxycytidine is a potent anti-alphavirus compound that induces a high level of mutations in the viral genome publication-title: J Virol doi: 10.1128/JVI.01965-17 – volume: 369 start-page: 956 issue: 6506 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0031 article-title: Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model publication-title: Science doi: 10.1126/science.abc7520 – volume: 14 start-page: 14 issue: 12 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0108 article-title: Clinical improvement with pirfenidone in two patients of COVID 19 publication-title: J Clin Diagnostic Res – year: 2022 ident: 10.1016/j.ebiom.2022.104185_bib0127 article-title: Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis publication-title: Eur Respir J doi: 10.1183/13993003.02951-2021 – volume: 9 start-page: 747 issue: 7 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0047 article-title: 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(21)00174-0 – volume: 13 start-page: 197 issue: 1 year: 2014 ident: 10.1016/j.ebiom.2022.104185_bib0093 article-title: Endoplasmic reticulum stress activates telomerase publication-title: Aging Cell doi: 10.1111/acel.12161 – volume: 353 start-page: 1374 issue: 13 year: 2005 ident: 10.1016/j.ebiom.2022.104185_bib0056 article-title: Avian influenza A (H5N1) infection in humans publication-title: N Engl J Med doi: 10.1056/NEJMra052211 – volume: 18 start-page: 773 issue: 5 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0004 article-title: Lungs after COVID-19: evolving knowledge of post-COVID-19 interstitial lung disease publication-title: Ann Am Thorac Soc doi: 10.1513/AnnalsATS.202102-223ED – volume: 2011 year: 2011 ident: 10.1016/j.ebiom.2022.104185_bib0012 article-title: Diffuse alveolar damage: a common phenomenon in progressive interstitial lung disorders publication-title: Pulm Med doi: 10.1155/2011/531302 – volume: 52 start-page: 130 issue: 1 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0125 article-title: TGF-β1/IL-11/MEK/ERK signaling mediates senescence-associated pulmonary fibrosis in a stress-induced premature senescence model of Bmi-1 deficiency publication-title: Exp Mol Med doi: 10.1038/s12276-019-0371-7 – volume: 141 start-page: 7 year: 2018 ident: 10.1016/j.ebiom.2022.104185_bib0113 article-title: Role of IL-15 in interstitial lung diseases in amyopathic dermatomyositis with anti-MDA-5 antibody publication-title: Respir Med doi: 10.1016/j.rmed.2018.06.012 – volume: 76 start-page: 1242 issue: 12 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0119 article-title: Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length publication-title: Thorax doi: 10.1136/thoraxjnl-2021-217031 – volume: 23 start-page: 2376 issue: 20 year: 2009 ident: 10.1016/j.ebiom.2022.104185_bib0100 article-title: Ly6d marks the earliest stage of B-cell specification and identifies the branchpoint between B-cell and T-cell development publication-title: Genes Dev doi: 10.1101/gad.1836009 – volume: 12 start-page: 19911 issue: 20 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0118 article-title: Short telomeres increase the risk of severe COVID-19 publication-title: Aging (Albany NY) doi: 10.18632/aging.104097 – volume: 21 start-page: 319 issue: 5 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0084 article-title: Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19 publication-title: Nat Rev Immunol doi: 10.1038/s41577-021-00536-9 – volume: 132 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0097 article-title: Cell senescence and fibrotic lung diseases publication-title: Exp Gerontol doi: 10.1016/j.exger.2020.110836 – volume: 10 start-page: e224 issue: 7 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0046 article-title: Persistent viral activity, cytokine storm, and lung fibrosis in a case of severe COVID-19 publication-title: Clin Transl Med doi: 10.1002/ctm2.224 – volume: 17 start-page: 2312 issue: 9 year: 2016 ident: 10.1016/j.ebiom.2022.104185_bib0092 article-title: Emergence of a wave of wnt signaling that regulates lung alveologenesis by controlling epithelial self-renewal and differentiation publication-title: Cell Rep doi: 10.1016/j.celrep.2016.11.001 – volume: 22 start-page: 1025 issue: 9 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0096 article-title: A transitional stem cell state in the lung publication-title: Nat Cell Biol doi: 10.1038/s41556-020-0561-5 – volume: 46 start-page: D649 issue: D1 year: 2018 ident: 10.1016/j.ebiom.2022.104185_bib0020 article-title: The reactome pathway knowledgebase publication-title: Nucleic Acids Res doi: 10.1093/nar/gkx1132 – volume: 10 start-page: e66417 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0028 article-title: Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19 publication-title: Elife doi: 10.7554/eLife.66417 – volume: 14 issue: 11 year: 2019 ident: 10.1016/j.ebiom.2022.104185_bib0034 article-title: Histochemical quantification of collagen content in articular cartilage publication-title: PLoS One doi: 10.1371/journal.pone.0224839 – volume: 199 start-page: 1517 issue: 12 year: 2019 ident: 10.1016/j.ebiom.2022.104185_bib0044 article-title: Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201712-2410OC – volume: 21 start-page: 2269 issue: 7 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0064 article-title: Alveolar epithelial type II cells as drivers of lung fibrosis in idiopathic pulmonary fibrosis publication-title: Int J Mol Sci doi: 10.3390/ijms21072269 – volume: 203 start-page: 707 issue: 6 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0070 article-title: Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.202004-1274OC – volume: 52 start-page: 217 issue: 2 year: 2015 ident: 10.1016/j.ebiom.2022.104185_bib0040 article-title: A novel genomic signature with translational significance for human idiopathic pulmonary fibrosis publication-title: Am J Respir Cell Mol Biol doi: 10.1165/rcmb.2013-0310OC – volume: 108 start-page: E1475 issue: 52 year: 2011 ident: 10.1016/j.ebiom.2022.104185_bib0090 article-title: Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1117988108 – volume: 49 issue: 10 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0011 article-title: Functional outcomes and their association with physical performance in mechanically ventilated coronavirus disease 2019 survivors at 3 months following hospital discharge: a cohort study publication-title: Crit Care Med doi: 10.1097/CCM.0000000000005089 – volume: 11 start-page: eaax5866 issue: 515 year: 2019 ident: 10.1016/j.ebiom.2022.104185_bib0074 article-title: Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia publication-title: Sci Transl Med doi: 10.1126/scitranslmed.aax5866 – volume: 108 start-page: 970 issue: 6 year: 2001 ident: 10.1016/j.ebiom.2022.104185_bib0112 article-title: Expression of IL-15 in inflammatory pulmonary diseases publication-title: J Allergy Clin Immunol doi: 10.1067/mai.2001.119556 – volume: 367 start-page: 1814 issue: 19 year: 2012 ident: 10.1016/j.ebiom.2022.104185_bib0057 article-title: Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia publication-title: N Engl J Med doi: 10.1056/NEJMoa1211721 – volume: 599 start-page: 283 issue: 7884 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0128 article-title: Virus-induced senescence is a driver and therapeutic target in COVID-19 publication-title: Nature doi: 10.1038/s41586-021-03995-1 – volume: 11 start-page: 3559 issue: 1 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0068 article-title: Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis publication-title: Nat Commun doi: 10.1038/s41467-020-17358-3 – volume: 46 start-page: 239 issue: 3 year: 2016 ident: 10.1016/j.ebiom.2022.104185_bib0102 article-title: Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease publication-title: Shock doi: 10.1097/SHK.0000000000000633 – volume: 51 start-page: 56 issue: 1 year: 2010 ident: 10.1016/j.ebiom.2022.104185_bib0052 article-title: The new influenza A H1N1 virus: balancing on the interface of humans and animals publication-title: Can Vet J – volume: 7 start-page: 1554 issue: 1 year: 2017 ident: 10.1016/j.ebiom.2022.104185_bib0041 article-title: Detecting the molecular system signatures of idiopathic pulmonary fibrosis through integrated genomic analysis publication-title: Sci Rep doi: 10.1038/s41598-017-01765-6 – volume: 26 start-page: 842 issue: 6 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0059 article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 publication-title: Nat Med doi: 10.1038/s41591-020-0901-9 – volume: 8 start-page: 750 issue: 8 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0001 article-title: Pulmonary fibrosis secondary to COVID-19: a call to arms? publication-title: Lancet Respir Med doi: 10.1016/S2213-2600(20)30222-8 – volume: 10 issue: 2 year: 2015 ident: 10.1016/j.ebiom.2022.104185_bib0024 article-title: A cell-based systems biology assessment of human blood to monitor immune responses after influenza vaccination publication-title: PLoS One doi: 10.1371/journal.pone.0118528 – volume: 30 start-page: 1770 issue: 14 year: 2019 ident: 10.1016/j.ebiom.2022.104185_bib0133 article-title: Unbiased Boolean analysis of public gene expression data for cell cycle gene identification publication-title: Mol Biol Cell doi: 10.1091/mbc.E19-01-0013 – volume: 10 start-page: 531 issue: 7 year: 2019 ident: 10.1016/j.ebiom.2022.104185_bib0063 article-title: SCINA: a semi-supervised subtyping algorithm of single cells and bulk samples publication-title: Genes (Basel) doi: 10.3390/genes10070531 – volume: 40 issue: 5 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0081 article-title: An organoid-derived bronchioalveolar model for SARS-CoV-2 infection of human alveolar type II-like cells publication-title: EMBO J doi: 10.15252/embj.2020105912 – volume: 56 start-page: 1 year: 2020 ident: 10.1016/j.ebiom.2022.104185_bib0006 article-title: Association of COVID-19 and other viral infections with interstitial lung diseases, pulmonary fibrosis, and pulmonary hypertension: a narrative review publication-title: Can J Respir Ther – volume: 1 start-page: e90558 issue: 20 year: 2016 ident: 10.1016/j.ebiom.2022.104185_bib0123 article-title: Single-cell RNA sequencing identifies diverse roles of epithelial cells in idiopathic pulmonary fibrosis publication-title: JCI Insight doi: 10.1172/jci.insight.90558 – volume: 13 start-page: eabj7790 issue: 620 year: 2021 ident: 10.1016/j.ebiom.2022.104185_bib0130 article-title: Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19 publication-title: Sci Transl Med doi: 10.1126/scitranslmed.abj7790 – reference: 34873597 - bioRxiv. 2022 Jul 18:2021.11.28.470269. doi: 10.1101/2021.11.28.470269 |
SSID | ssj0001542358 |
Score | 2.3647463 |
Snippet | In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack insights into... SummaryBackgroundIn the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post- COVID-19 lung disease (PCLD), for which we currently... Background: In the aftermath of Covid-19, some patients develop a fibrotic lung disease, i.e., post-COVID-19 lung disease (PCLD), for which we currently lack... |
SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 104185 |
SubjectTerms | Adult Advanced Basic Science Alveolar type II pneumocytes Animals Artificial intelligence/machine learning COVID-19 Cytokine Release Syndrome Damage-associated transient progenitor (DATP) ER-stress Humans Idiopathic Pulmonary Fibrosis - genetics Idiopathic Pulmonary Fibrosis - metabolism Immune response Interleukin 15 (IL15) Internal Medicine Lung - pathology Mice SARS-CoV-2 Senescence |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiDfhJSNxJMJx_IiPpVC1SMCBFvWE5Ti2utUqW212D_vvmbGT1S6g9sI1ifOYGXu-iWe-IeQd64JDZiqITbQsRdSsbIWpS8dirRpwsj6Vj339pk7OxZcLebHT6gtzwjI9cBbch05GY7yEuWCcQH47F8ClN8xrJ2PrE88nM2wnmMr1wQJrQFNnOcnL2igxUQ6l5K6Axe0QHXKOm5wVdlLecUuJvX_PO_2NPv9MotzxSscPyP0RTtLD_BkPyZ3QPyJ3c4PJzWPy6-j7z9NPZWXoHCY1HXdj6HCJVUe0W2JSBj0849RvVovUnNjTGBLX50DxFy097WbTiev1HGzWLTc0Qoy9GGbDE3J-_Pns6KQcOyqUXtV8VTZt55lxAOoE1x6wi6u446EJQUplwJ1pF8GnayEAZbSx7prAXNOaymkQPqC1p-SgX_ThOcGXkY5H18YqiuAbVykDsmicalUttC8InwRq_Ug3jl0v5nbKK7uySQsWtWCzFgryfjvoOrNt3Hz5R9TU9lKkyk4HwIDsaED2NgMqiJj0bKdqVFg_4Uazm5-t_zUsDOMaMNjKDtwy-wMtEA2QYx6gUk1B1HbkCHMyfLn9kW8nM7SwCODOjuvDYj1YrgwSRwKWL8izbJZbocA00BgYwwvvGeye1PbP9LPLRDQO0BkApH7xP8T8ktzDT8m5k6_IwWq5Dq8Bz63aN2nq_gYcFEVJ priority: 102 providerName: Directory of Open Access Journals |
Title | COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2352396422003668 https://www.clinicalkey.es/playcontent/1-s2.0-S2352396422003668 https://dx.doi.org/10.1016/j.ebiom.2022.104185 https://www.ncbi.nlm.nih.gov/pubmed/35870428 https://www.proquest.com/docview/2693779977 https://pubmed.ncbi.nlm.nih.gov/PMC9297827 https://doaj.org/article/d5f99c58879a40249ae39280c7a5fbc3 |
Volume | 82 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKEaiXijdboDISR4ISx7HjA0KlULVIhQNd1BOW49jtolVSkl2J_ffMJPFCYFUkrokncWbGnm_ieRDyIi6dwcpU4JvILOJexlHBVRqZ2KciByNru_Sx04_ieMo_nGfnWyR0RR0Y2G507bCf1LSZv_rxffUGFvzrX7FaDnPVwdljDM8swQTdIDfBNAn0xk4HvN-nDXNMDQ3VhzbT7pDbMEaiMzEyVl1N_5HN-huT_hla-ZutOrpDdgeQSQ96rbhLtlx1j9zq206u7pOvh5--nLyLEkXnsNTpcEZD20vMRaJlg6Ea9OCMUbta1F3LYku96yqAthR_3NKTchZuXC3noMmmWVEPnnfdztoHZHr0_uzwOBr6LERWpGwR5UVpY2UA6nEmLSAakzDDXO5clgkFRk4aD5Zecg7Yo_BpmbvY5IVKjDQcMdxDsl3VlXtMcDKZYd4UPvHc2dwkQgEvciMKkXJpJ4QFhmo7FCHHXhhzHaLNvulOIBoFonuBTMjLNdFVX4Pj-uFvUVLroVhAu7tQNxd6WI-6zLxSNoMtVsE3gA9qHCDFPLbSZL6w6YTwIGcdclRhV4UHza5_t9xE5tqg2DrRLdOx_gx6yFIF3h9GBwqRT4hYUw7gpwc1_37l86CGGrYGPO8xlauXrWZCYTlJQPgT8qhXyzVTgobDhEcKO-La-E41u-zKjwOgBlgp9_6b8gnZwfn3YZRPyfaiWbpnAO0WxX73S2S_W7Q_AfolTbw |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=COVID-19+lung+disease+shares+driver+AT2+cytopathic+features+with+Idiopathic+pulmonary+fibrosis&rft.jtitle=EBioMedicine&rft.au=Sinha%2C+Saptarshi&rft.au=Castillo%2C+Vanessa&rft.au=Espinoza%2C+Celia+R.&rft.au=Tindle%2C+Courtney&rft.date=2022-08-01&rft.pub=Elsevier&rft.eissn=2352-3964&rft.volume=82&rft_id=info:doi/10.1016%2Fj.ebiom.2022.104185&rft_id=info%3Apmid%2F35870428&rft.externalDocID=PMC9297827 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F23523964%2Fcov200h.gif |